Vega Harwood, A.W.; Fernández, M.M.; Ezquer Garin, C.; Álvarez, F.J.; López Herrero, R.; Tamayo, E.; Aguilar, G.
Antimicrobial Dosing During Continuous Venovenous Hemodiafiltration in Septic Shock Patients: A Prospective, Multicenter Study Protocol. Antibiotics 2025, 14, 420.
https://doi.org/10.3390/antibiotics14040420
AMA Style
Vega Harwood AW, Fernández MM, Ezquer Garin C, Álvarez FJ, López Herrero R, Tamayo E, Aguilar G.
Antimicrobial Dosing During Continuous Venovenous Hemodiafiltration in Septic Shock Patients: A Prospective, Multicenter Study Protocol. Antibiotics. 2025; 14(4):420.
https://doi.org/10.3390/antibiotics14040420
Chicago/Turabian Style
Vega Harwood, Alicia Wendy, Marta Martín Fernández, Carlos Ezquer Garin, Francisco Javier Álvarez, Rocío López Herrero, Eduardo Tamayo, and Gerardo Aguilar.
2025. "Antimicrobial Dosing During Continuous Venovenous Hemodiafiltration in Septic Shock Patients: A Prospective, Multicenter Study Protocol" Antibiotics 14, no. 4: 420.
https://doi.org/10.3390/antibiotics14040420
APA Style
Vega Harwood, A. W., Fernández, M. M., Ezquer Garin, C., Álvarez, F. J., López Herrero, R., Tamayo, E., & Aguilar, G.
(2025). Antimicrobial Dosing During Continuous Venovenous Hemodiafiltration in Septic Shock Patients: A Prospective, Multicenter Study Protocol. Antibiotics, 14(4), 420.
https://doi.org/10.3390/antibiotics14040420